Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

Eboni I. Lance, MD, Lisa Faulcon, MD, Zongming Fu, PhD, Jun Yang, PhD, Donna Whyte, MD, John J. Strouse, MD, PhD, Emily Barron-Casella, PhD, Kimberly Jones, Jennifer Van Eck, PhD, James F. Casella, MD, Allen Everett, MD

Blood (2019) 134 (Supplement_1): 2296.

https://doi.org/10.1182/blood-2019-122015

Published: 2019

Journal Articles

Neurodevelopmental Disorders in Pediatric Sickle Cell Disease

Eboni I. Lance, MD, Alicia D. Cannon, PhD, Bruce K. Shapiro, MD, Michael V. Johnston, MD, James F. Casella, MD

Blood (2019) 134 (Supplement_1): 1016.

https://doi.org/10.1182/blood-2019-121968

Published: 2019

Journal Articles

Allergic Sensitization Is Associated with Decreased Risk of ED Visits and Hospitalizations for Pain in Sickle Cell Disease

Christy Sadreameli, MD, M.H.S., Benjamin Kopp, MD, M.P.H., Susan E Creary, MD, Emily Jacobs, B.S., John J Strouse, MD PhD, Sharon A. McGrath-Morrow, MD, James F. Casella, MD, Elizabeth C. Matsui

Blood (2018) 132 (Supplement 1): 3676.

https://doi.org/10.1182/blood-2018-99-119743

Published: 2018

Journal Articles

Quantification of Whole-Brain Oxygenation Extraction Fraction Among People with Sickle Cell Anemia without Stroke History

Wenbo Li, PhD, Xiang Xu, PhD, Peiying Liu, PhD, Emily Jacobs, B.S., John J. Strouse, MD PhD, James F. Casella, MD, Hanzhang Lu, PhD, Peter van Zijl, PhD, Qin Qin, PhD

Blood (2017) 130 (Supplement 1): 3524.

https://doi.org/10.1182/blood.V130.Suppl_1.3524.3524

Published: 2017

Journal Articles

Cost-Effectiveness of Blood Transfusions Versus Observation for Silent Cerebral Infarcts from the Silent Cerebral Infarct Trial

James C. Gay, MD MMHC, Timothy McCavit, MD, David Bundy, MD MPH, Allison King, MD MPH, PhD, Harold P. Lehman, MD, John J. Strouse, MD PhD, James F. Casella, MD, Mark J. Rodeghier, PhD, Michael DeBaun, MD

Blood (2016) 128 (22): 3655.

https://doi.org/10.1182/blood.V128.22.3655.3655

Published: 2016

Journal Articles

Hospitalization for Acute Pain in Sickle Cell Disease: Changes in Clinical Parameters and Factors Predicting Hospital Discharge and Re-Admission

Mehdi Nouraie, MD PhD, Debra L Weiner, MD, Mariana Hildesheim, MS, Ward Hagar, MD, Oswaldo L Castro, MD, Sophie Lanzkron, MD MHS, Victor R. Gordeuk, MD, James F. Casella, MD, Mark T. Gladwin, MD, Gregory J. Kato, MD

Blood (2016) 128 (22): 3662.

https://doi.org/10.1182/blood.V128.22.3662.3662

Published: 2016

Journal Articles

Progressive Loss of Brain Volume in Children with Sickle Cell Anemia: A Report from the Silent Cerebral Infarct Transfusion Trial Cohort

Odianosen Eigbire-Molen, Deepika S. Darbari, MD, Maria R. Ponisio, MD, Mikhail V. Milchenko, PhD, Mark J. Rodeghier, PhD, James F. Casella, MD, Robert McKinstry, MD PhD, Michael R. DeBaun, MD MPH

Blood (2015) 126 (23): 546.

https://doi.org/10.1182/blood.V126.23.546.546

Published: 2015

Journal Articles

Health-Related Quality of Life in Children with Sickle Cell Disease: Impact of Blood Transfusion Therapy

Lauren M Beverung, MS, PhD, John J. Strouse, MD PhD, Monica L. Hulbert, MD, Kathleen A Neville, MD MS, Robert I. Liem, MD, Baba PD Inusa, MD FRCPCH, DCP, Beng Fuh, MD, Allison King, MD MPH, Emily R. Meier, MD, James F. Casella, MD, Michael R. DeBaun, MD MPH, Julie A. Panepinto, MD MSPH

Blood (2014) 124 (21): 2167.

https://doi.org/10.1182/blood.V124.21.2167.2167

Published: 2014

Journal Articles

Effects of Hydroxyurea (HU) On Lymphocyte Subsets and the Immune Response to Pneumococcal, Measles, Mumps and Rubella Vaccination in the Pediatric Hydroxyurea Phase III Clinical Trial - BABY HUG - (ClinicalTrials.gov Identifier: NCT00006400)

Howard M. Lederman, MD, PhD, Margaret A. Connolly, PhD, Ram Kalpatthi, MD, Russell E. Ware, MD, PhD, Winfred C. Wang, MD, Lori Luchtman-Jones, MD, Myron Waclawiw, PhD, Jonathan C. Goldsmith, MD, James F. Casella, MD

Blood (2012) 120 (21): 243.

https://doi.org/10.1182/blood.V120.21.243.243

Published: 2012

Journal Articles

The Physiological and Clinical Effects of Interrupting a Treatment Regimen of Hydroxyurea in Young Children with Sickle Cell Anemia (SCA)

Bruce W Thompson, PhD, Winfred C Wang, MD, Scott T. Miller, MD, Zora R. Rogers, MD, Russell E. Ware, MD, PhD, Courtney D. Thornburg, MD, MS, Sohail R. Rana, MD, Lori Luchtman-Jones, MD, Rathi V. Iyer, MD, James F. Casella, MD

Blood (2011) 118 (21): 2134.

https://doi.org/10.1182/blood.V118.21.2134.2134

Published: 2011

Journal Articles

ACUTE CHEST SYNDROME with RESPIRATORY Syncytial VIRUS and SEASONAL INFLUENZA In CHILDREN with SICKLE CELL DISEASE

John J. Strouse, MD, Sara C Sadreameli, MD, James F. Casella, MD

Blood (2011) 118 (21): 4845.

https://doi.org/10.1182/blood.V118.21.4845.4845

Published: 2011

Journal Articles

Hydroxyurea Treatment of Young Children with Sickle Cell Anemia: Safety and Efficacy of Continued Treatment – the BABY HUG Follow-up Study

Zora R. Rogers, MD, Billie Fish, CCRP, Zhaoyu Luo, PhD, Rathi V. Iyer, MD, Courtney D. Thornburg, MD, MS, Sharada A. Sarnaik, MD, Sohail R. Rana, MD, Lori Luchtman-Jones, MD, Sherron M. Jackson, MD, Thomas H. Howard, MD, James F. Casella, MD, R. Clark Brown, MD, PhD, Ofelia A. Alvarez, MD, Jonathan C. Goldsmith, MD, Scott T. Miller, MD, Winfred C. Wang, MD

Blood (2011) 118 (21): 7.

https://doi.org/10.1182/blood.V118.21.7.7

Published: 2011

Journal Articles

Identification of Thrombospondin-1 and L-Selectin as Potential Plasma Biomarkers of Silent Cerebral Infarct In Children with Sickle Cell Disease Using a Proteomic-Based Approach

Lisa M. Williams, MD, Zongming Fu, PhD, Pratima Dulloor, Kun Yan, PhD, John J. Strouse, MD, PhD, William Savage, MD, Emily Barron-Casella, PhD, Michael R. DeBaun, MD, MPH, Jennifer E. Van Eyk, PhD, Allen Everett, MD, James F. Casella, MD

Blood (2010) 116 (21): 259.

https://doi.org/10.1182/blood.V116.21.259.259

Published: 2010

Journal Articles

Influence of Hemoglobin Level on Clinical Findings In Infants with Sickle Cell Anemia: Data From BABY HUG

Jeffrey D. Lebensburger, DO, Scott T Miller, MD, Thomas H. Howard, MD, James F. Casella, MD, R. Clark Brown, MD, PhD, Ming Lu, MS, Rathi V. Iyer, MD, Zora R. Rogers, MD, Winfred C. Wang, MD

Blood (2010) 116 (21): 1631.

https://doi.org/10.1182/blood.V116.21.1631.1631

Published: 2010

Journal Articles

Acute Silent Cerebral Ischemia Occurs More Frequently Than Silent Cerebral Infarction In Children with Sickle Cell Anemia

Charles T. Quinn, MD, MS, Robert C. McKinstry, MD, PhD, Michael M. Dowling, MD, PhD, MSCS, William S. Ball, MD, Michael A. Kraut, MD, PhD, James F. Casella, MD, Nomazulu Dlamini, MBBS, MRCPCH, MSc, Rebecca N. Ichord, MD, Lori C. Jordan, MD, Fenella J. Kirkham, MD, FRCPCH, Michael J. Noetzel, MD, E. Steve Roach, MD, Deborah Hirtz, MD, Michael R. DeBaun, MD, MPH

Blood (2010) 116 (21): 268.

https://doi.org/10.1182/blood.V116.21.268.268

Published: 2010

Journal Articles

Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.

Blood (2009) 114 (22): 262.

https://doi.org/10.1182/blood.V114.22.262.262

Published: 2009

Journal Articles

Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease.

Lisa M. Williams, MD, Zongming Fu, PhD, Pratima Dulloor, William J Savage, MD, Emily Barron-Casella, PhD, John J. Strouse, MD, PhD, Michael R. DeBaun, MD, MPH, Jennifer Van Eyk, PhD, Allen Everett, MD, James F. Casella, MD

Blood (2009) 114 (22): 2579.

https://doi.org/10.1182/blood.V114.22.2579.2579

Published: 2009

Journal Articles

Low Levels of Apolipoprotein A1 Are Associated with Silent Cerebral Infarcts in Children with Sickle Cell Disease.

John J. Strouse, MD, Michael Kraut, MD, PhD, Lisa M. Williams, MD, Michael R. DeBaun, MD, MPH, James F. Casella, MD

Blood (2009) 114 (22): 259.

https://doi.org/10.1182/blood.V114.22.259.259

Published: 2009

Journal Articles

Increased Severity of Pandemic H1N1 Influenza in Children and Young Adults with Sickle Cell Disease.

John J. Strouse, MD, PhD, Martha Amoako, B.S., Megan Reller, M.D., M.P.H., James F. Casella, MD

Blood (2009) 114 (22): 264.

https://doi.org/10.1182/blood.V114.22.264.264

Published: 2009

Journal Articles

Genome-Wide Association for Silent Cerebral Infarction (SCI) in Sickle Cell Disease: The Silent Infarct Transfusion Trial (SIT) Cohort.

Pallav Bhatnagar, PhD, Emily Barron Casella, Dan E Arking, PhD, James F. Casella, MD

Blood (2009) 114 (22): 2563.

https://doi.org/10.1182/blood.V114.22.2563.2563

Published: 2009

NARROW

Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease

Neurodevelopmental Disorders in Pediatric Sickle Cell Disease

Allergic Sensitization Is Associated with Decreased Risk of ED Visits and Hospitalizations for Pain in Sickle Cell Disease

Quantification of Whole-Brain Oxygenation Extraction Fraction Among People with Sickle Cell Anemia without Stroke History

Cost-Effectiveness of Blood Transfusions Versus Observation for Silent Cerebral Infarcts from the Silent Cerebral Infarct Trial

Hospitalization for Acute Pain in Sickle Cell Disease: Changes in Clinical Parameters and Factors Predicting Hospital Discharge and Re-Admission

Progressive Loss of Brain Volume in Children with Sickle Cell Anemia: A Report from the Silent Cerebral Infarct Transfusion Trial Cohort

Health-Related Quality of Life in Children with Sickle Cell Disease: Impact of Blood Transfusion Therapy

Effects of Hydroxyurea (HU) On Lymphocyte Subsets and the Immune Response to Pneumococcal, Measles, Mumps and Rubella Vaccination in the Pediatric Hydroxyurea Phase III Clinical Trial - BABY HUG - (ClinicalTrials.gov Identifier: NCT00006400)

The Physiological and Clinical Effects of Interrupting a Treatment Regimen of Hydroxyurea in Young Children with Sickle Cell Anemia (SCA)

ACUTE CHEST SYNDROME with RESPIRATORY Syncytial VIRUS and SEASONAL INFLUENZA In CHILDREN with SICKLE CELL DISEASE

Hydroxyurea Treatment of Young Children with Sickle Cell Anemia: Safety and Efficacy of Continued Treatment – the BABY HUG Follow-up Study

Identification of Thrombospondin-1 and L-Selectin as Potential Plasma Biomarkers of Silent Cerebral Infarct In Children with Sickle Cell Disease Using a Proteomic-Based Approach

Influence of Hemoglobin Level on Clinical Findings In Infants with Sickle Cell Anemia: Data From BABY HUG

Acute Silent Cerebral Ischemia Occurs More Frequently Than Silent Cerebral Infarction In Children with Sickle Cell Anemia

Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.

Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease.

Low Levels of Apolipoprotein A1 Are Associated with Silent Cerebral Infarcts in Children with Sickle Cell Disease.

Increased Severity of Pandemic H1N1 Influenza in Children and Young Adults with Sickle Cell Disease.

Genome-Wide Association for Silent Cerebral Infarction (SCI) in Sickle Cell Disease: The Silent Infarct Transfusion Trial (SIT) Cohort.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only